FDA Grants Third Orphan Drug Designation for OS2966
STAMFORD, CONNECTICUT, January 10, 2023. Research at Children’s Hospital Los Angeles has resulted in a novel therapeutic receiving orphan drug status from the Food and Drug Administration (FDA) for the…